News Home

Does Eli Lilly And Co (LLY) Have What it Takes to be in Your Portfolio Monday?

Monday, April 01, 2024 11:28 AM | InvestorsObserver Analysts

Mentioned in this article

Does Eli Lilly And Co (LLY) Have What it Takes to be in Your Portfolio Monday?

A rating of 96 puts Eli Lilly And Co (LLY) near the top of the Drug Manufacturers - General industry according to InvestorsObserver. Eli Lilly And Co's score of 96 means it scores higher than 96% of stocks in the industry. Eli Lilly And Co also received an overall rating of 77, putting it above 77% of all stocks. Drug Manufacturers - General is ranked 101 out of the 148 industries.

Overall Score - 77
LLY has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on LLY!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Eli Lilly And Co Stock Today?

Eli Lilly And Co (LLY) stock is trading at $757.00 as of 11:22 AM on Monday, Apr 1, a loss of -$20.96, or -2.69% from the previous closing price of $777.96. The stock has traded between $755.33 and $777.50 so far today. Volume today is low. So far 1,207,842 shares have traded compared to average volume of 3,055,411 shares. Click Here to get the full Stock Report for Eli Lilly And Co stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App